Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH1243598427
Wed, 25.02.2026
Sandoz Group AG
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules
Basel, February 25, 2026 – Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today presents its financial results for the full year and net sales for the fourth quarter of 2025.
FINANCIAL RESULTS
FY 2025
FY 2024
[ … ]
Wed, 18.02.2026
Sandoz Group AG
Sandoz Group AG
/ Key word(s): Regulatory Approval
Sandoz receives US FDA approval to expand Enzeevu® (aflibercept-abzv) label for multiple retinal indications 18.02.2026 / 07:00 CET/CEST
MEDIA RELEASE
Approved indications now include all retinal indications, in addition to previously-approved indication of nAMD
More than 30 [ … ]
Wed, 14.01.2026
Sandoz Group AG
Sandoz Group AG
/ Key word(s): Regulatory Approval
Sandoz confirms European Commission approval of Ondibta® (insulin glargine), strengthening overall biosimilars leadership and position in diabetes 14.01.2026 / 12:00 CET/CEST
Biosimilar Ondibta® (insulin glargine) approved for treatment of diabetes mellitus across all indicati [ … ]
Mon, 12.01.2026
Sandoz Group AG
Sandoz Group AG
/ Key word(s): Conference
Sandoz CEO, speaking at 44th Annual J.P. Morgan Healthcare Conference, will outline plans to capitalize on unprecedented ’golden decade’ of affordable medicines opportunity 12.01.2026 / 15:00 CET/CEST
After consistently delivering on commitments in first two years as standalone compan [ … ]
